BioSpace News Archive

Employer Resources

Webinar: Recruiting Strategies for 2022: Winning Biopharma’s Struggle for Talent

In BioSpace’s latest webinar, we covered topics including proactive recruitment strategies, remote hiring, compensation negotiating and employee retention.

October 6, 2023
·
2 min read
·
Chantal Dresner
Spexis to host business update conference call on October 9, 2023

Spexis AG announced that it will host a business update conference call on October 9, 2023, at 8.30am EDT.

October 6, 2023
·
1 min read
Bio NC

Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023

Verona Pharma plc, announces it will hold an Investor Update in New York City for investors and analysts on Wednesday, October 18, 2023, from 8:00 - 10:00 AM ET.

October 6, 2023
·
6 min read
Drug Development

Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America

Moberg Pharma AB has completed the recruitment of 384 patients with onychomycosis for the ongoing MOB-015 phase 3 study in North America.

October 6, 2023
·
3 min read
UNION therapeutics announces presentation of new data on orismilast at the EADV Congress 2023

UNION therapeutics A/S announced acceptance of a late-breaking oral presentation at the European Academy of Dermatology and Venerology Congress 2023 on October 11-14, 2023, in Berlin, Germany.

October 6, 2023
·
4 min read
Biotech Bay

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - October 06, 2023

IDEAYA Biosciences, Inc. announced that, on September 28, 2023, the Compensation Committee of IDEAYA’s Board of Directors granted non-qualified stock options to purchase an aggregate of 17,800 shares of the Company’s common stock to a newly hired employee.

October 6, 2023
·
2 min read
Asceneuron Welcomes Barbara Angehrn Pavik as New CEO as It Gears Up for Next Phase of Growth

Asceneuron SA announced the appointment of Barbara Angehrn Pavik as the new Chief Executive Officer, as part of a leadership transition poised to propel the company into its next phase of growth, with two compounds in clinical development.

October 6, 2023
·
2 min read
Business

Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials

Paradigm announced a collaboration with Bristol Myers Squibb to build a new end-to-end clinical trial operating model across design, recruitment, and data collection.

October 6, 2023
·
2 min read
BioCapital

Immunocore announces upcoming presentation and posters at ESMO 2023

Immunocore announces upcoming presentation and posters at ESMO 2023 Long-term survival data for KIMMTRAK in previously untreated patients with metastatic uveal melanoma to be presented as a late-breaking abstract in a mini oral session.

October 6, 2023
·
7 min read
US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

Renalytix plc announces that the US Patent Office has issued a new notice of allowance of claims surrounding the biomarkers sTNFR1 and sTNFR2 used in the kidneyintelX.dkd test.

October 6, 2023
·
6 min read